Brief: Abionyx Pharma Successfully Manufactures Second Batch For GMP Industrial Biomanufacturing of CER-001

Abionyx Pharma SA

26/07/2023 17:38

July 26 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX PHARMA SUCCESSFULLY MANUFACTURES A SECOND BATCH OF
RECOMBINANT HUMAN APOA-I CER-001 USING A NEW, INNOVATIVE AND
ROBUST INDUSTRIAL BIOPROCESS
    * DEMONSTRATED SUCCESS FOR INDUSTRIAL BIOMANUFACTURING OF
CER001,
ONE OF THE MOST ADVANCED BIOMEDICINES
    * CONFIRMATION OF IMPROVED YIELD AND SIMPLIFICATION OF
BIOMANUFACTURING PROCESS
    * POSITIONING ON BIOMANUFACTURING TRAJECTORY REQUIRING 3
CONSECUTIVE BATCHES FOR MARKETING AUTHORIZATION

Source text for Eikon:  ID:nBw13wZLCa 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587696600;))